NDC properties for NDC 9 0245-0871
NDC item 00245087105
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-05 |
| NDC Item | 00245087105 |
| packaging | 30 TUBE in 1 CARTON (0245-0871-05) / 5 g in 1 TUBE (0245-0871-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
NDC item 00245087135
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-35 |
| NDC Item | 00245087135 |
| packaging | 30 PACKET in 1 CARTON (0245-0871-35) / 5 g in 1 PACKET (0245-0871-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
NDC item 00245087165
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-65 |
| NDC Item | 00245087165 |
| packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |
NDC item 00245087189
| NDC 9 | 0245-0871 |
|---|---|
| NDC 10 | 0245-0871-89 |
| NDC Item | 00245087189 |
| packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 677563 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-06-09 |
| Marketing status | ACTIVE |
| NDA | NDA204399 |